Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer

This study was designed to identify clinical predictors of favorable pathology and biochemical recurrence (BCR) in patients with intermediate-risk prostate cancer (IRPCa). Between 2006 and 2012, clinicopathological and oncological data from 203 consecutive men undergoing robot-assisted radical prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Ho Won, Jung, Hae Do, Lee, Joo Yong, Kwon, Jong Kyou, Jeh, Seong Uk, Cho, Kang Su, Ham, Won Sik, Choi, Young Deuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854109/
https://www.ncbi.nlm.nih.gov/pubmed/26178393
http://dx.doi.org/10.4103/1008-682X.154313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854109/
https://www.ncbi.nlm.nih.gov/pubmed/26178393
http://dx.doi.org/10.4103/1008-682X.154313

Ejemplares similares